Previous Article | Next Article ![]()
J. Virol., Apr 1997, 2793-2798, Vol 71, No. 4
MJ Bouchard and VR Racaniello
The identification of a monoclonal antibody, AF3, which recognizes a single
isoform of the cell surface protein CD44 and preferentially blocks binding
of serotype 2 poliovirus to HeLa cells, suggested that CD44 might be an
accessory molecule to Pvr, the cell receptor for poliovirus, and that it
could play a role in the function of the poliovirus receptor site. We show
here that only AF3 blocks binding of serotype 2 poliovirus to HeLa cells
and, in contrast to a previously published report, that the anti-CD44
monoclonal antibodies A3D8 and IM7 are unable to block binding of
poliovirus. To determine whether CD44 is involved in poliovirus infection,
we analyzed the replication of all three serotypes of poliovirus in human
neuroblastoma cells which lack or express CD44 and in mouse neuroblastoma
cells which lack Pgp-1, the mouse homolog of human CD44, and which express
Pvr. All three poliovirus serotypes replicate with normal kinetics and to
normal levels in the absence or presence of CD44 or in the absence of
Pgp-1. Furthermore, the binding affinity constants of all three poliovirus
serotypes for Pvr are unaffected by the presence or absence of CD44 in the
human neuroblastoma cell line. We conclude that CD44 and Pgp-1 are not
required for poliovirus replication and are unlikely to be involved in
poliovirus pathogenesis.
Copyright © 1997, American Society for Microbiology
CD44 is not required for poliovirus replication
Department of Microbiology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|